In fact, the expression of MAOB is increased in Alzheimer’s disease and Parkinson’s disease (14, 15), and MAOB inhibitors have been investigated as treatments for these diseases (16, 17). Here, MAOB is linked to early-onset autosomal dominant Alzheimer disease.